Becker's Healthcare May 24, 2024
Mariah Taylor

FDA advisers have recommended the approval of Guardant Health’s blood test to detect colon or rectal cancers — but it also raised some concerns, NBC News reported May 23.

The panel voted 7-2 in favor of approving Gaurdant’s test, Shield. If the FDA does approve it, it will be the second blood-based test for colon cancer, competing with Epigenomics’ Epi proColon, which was approved in...

Today's Sponsors


Today's Sponsor


Topics: FDA, Govt Agencies, Medical Devices, Patient / Consumer, Provider
Merck wins FDA OK for vaccine rival to Pfizer’s pneumococcal shot
Q&A: How Will the FDA Panel's Decision on MDMA Impact the Future of Psychedelic Medicine?
FDA approves 1st adult vaccine for bacterial pneumonia
FDA Approves Pneumococcal 21-Valent Conjugate Vaccine Capvaxive
FDA tells providers to prepare for supply chain disruptions

Share This Article